Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Teduglutide for Treatment of Enterocutaneous Fistula (ECF) - a Pilot Study to Demonstrate Safety and Feasibility

NCT02889393 is registered in ClinicalTrials.gov with Daniel Dante Yeh as lead sponsor.

NCT NCT02889393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Teduglutide for Treatment of Enterocutaneous Fistula (ECF) - a Pilot Study to Demonstrate Safety and Feasibility
Lead sponsor
Daniel Dante Yeh
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2019
Completion date
July 15, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative fistula